12 Drugs to Avoid if You Have Obstructive Hypertrophic Cardiomyopathy

Living with obstructive hypertrophic cardiomyopathy (oHCM) means taking care to avoid things that could trigger or worsen your symptoms. That includes the medications you take.
Certain medications can make this worse by forcing the heart muscle to contract or squeeze more forcefully, further narrowing the path of blood flow, says Alec Kherlopian, MD, a cardiologist at Loma Linda University Health in California.
Here are 12 of the most common offenders. Use this info as a starting point for a conversation with your cardiologist about managing your oHCM treatment plan.
1. Vasodilators
Medications that help blood vessels relax and expand are often used to treat high blood pressure. But they can worsen symptoms when you have oHCM, especially if your symptoms aren’t well-managed. “Vasodilators decrease resistance in the body’s arteries, which forces the heart to squeeze harder. As a result, an oHCM patient might feel more shortness of breath or chest pain,” says Ronald Wharton, MD, director of the Hypertrophic Cardiomyopathy Program at Sandra Atlas Bass Heart Hospital at North Shore University Hospital in Manhasset, New York.
- Dihydropyridine class calcium channel blockers like amlodipine (Norvasc) and nifedipine. Non-dihydropyridine class calcium channel blockers like verapamil and diltiazem (Cardizem, Tiazac) work differently, so they’re safe for people with oHCM.
- Angiotensin-converting enzyme (ACE) inhibitors like Lisinopril (Prinivil, Zestril), Enalapril (Vasotec), Ramipril (Altace), Benazepril (Lotensin), and Quinapril (Accupril)
- Angiotensin receptor blockers like losartan (Cozaar), valsartan (Diovan), and olmesartan (Benicar)
- Hydralazine (Apresoline), a direct vasodilator
- Nitrates like nitroglycerin
If you have high blood pressure, your cardiology team will help you find a safer therapy for managing your blood pressure, such as a non-dihydropyridine class calcium channel blocker, says Dr. Kherlopian.
2. Diuretics
“I generally don’t use any diuretics if a patient has symptomatic HCM,” says Kherlopian. “If the patient is adequately treated with medications or surgery, then a diuretic can safely be used.”
- Thiazide diuretics like chlorothiazide, hydrochlorothiazide (Microzide, Oretic), chlorthalidone (Hemiclor, Thalitone), indapamide, and metolazone
- Loop diuretics like bumetanide (Bumex), ethacrynic acid (Edecrin), furosemide (Lasix, Furoscix), torsemide (Soaanz)
- Potassium-sparing diuretics like amiloride (Midamor), eplerenone (Inspra), spironolactone (Aldactone, CaroSpir), and triamterene (Dyrenium)
3. Digoxin
Digoxin brand names include Digitex, Digox, Lanoxicaps, and Lanoxin.
4. PDE5 Inhibitors
PDE5 inhibitors include:
- Sildenafil (Viagra)
- Tadalafil (Cialis)
- Vardenafil (Levitra)
5. Stimulants
6. Caffeine
Caffeine is a stimulant too. And while it’s not nearly as potent as stimulant medications, it may be worth keeping tabs on your intake — and cutting back if it affects your oHCM, Dr. Tapaskar says.
Not everyone needs to go completely caffeine-free. For many, a cup or two of coffee a day may be fine, Tapaskar says. “It’s hard to make one-size-fits-all recommendations. You should talk about it with your cardiologist,” she adds.
7. Decongestants
Some drug store decongestants can raise blood pressure and heart rate, worsening oHCM, Wharton says.
If you need relief from a stuffy nose, oral antihistamines and nasal sprays are safe for people with oHCM. Saline nasal sprays and neti pots can be effective too.
8. NSAIDs
Limit or avoid NSAID pain relievers like ibuprofen (Advil, Motrin), and naproxen sodium (Aleve). When you need pain relief, acetaminophen (Tylenol) is a safer option.
9. Alcohol
While you might opt to have a drink now and then on special occasions, regular drinking — even just a few drinks per week — isn’t ideal for people with oHCM. “Alcohol is a diuretic, so it can worsen obstructions and symptoms,” says Tapaskar, who encourages her patients to avoid alcohol altogether. If you choose to drink, talk with your doctor about a safe amount of alcohol for you.
10. Tobacco
If you need help quitting, talk with your doctor.
11. Herbal Supplements
12. Illegal Drugs

Cheng-Han Chen, MD, PhD, FACC, FSCAI
Medical Reviewer
Cheng-Han Chen, MD, PhD, is the medical director of the structural heart program at MemorialCare Saddleback Medical Center in Laguna Hills, California, and director of structural a...

Marygrace Taylor
Author
Marygrace Taylor is an award-winning freelance health and wellness writer with more than 15 years of experience covering topics including women’s health, nutrition, chronic conditi...
- Hypertrophic Cardiomyopathy. American Heart Association. May 29, 2024.
- Maron M et al. Hypertrophic Cardiomyopathy: Management of Patients With Outflow Tract Obstruction. UpToDate.com. March 2026.
- Meder B et al. EJHF Expert Consensus Statement on the Diagnosis and Management of Hypertrophic Cardiomyopathy. European Journal of Heart Failure. January 8, 2026.
- Ommen S et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. May 8, 2024.
- Medications and Hypertrophic Cardiomyopathy: What to Avoid, What to Discuss. Cleveland Clinic. March 26, 2026.
- Diuretics. Mayo Clinic. September 27, 2025.
- Digoxin (Oral Route). Mayo Clinic. March 31, 2026.
- Dhaliwal A et al. PDE5 Inhibitors. StatPearls. April 10, 2023.
- Ottaviani A et al. Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives. Journal of Clinical Medicine. September 1, 2023.
- Gerard P et al. ADHD Stimulant Use Associated With Increased Risk of Cardiomyopathy in Young Adults. Journal of the American College of Cardiology. April 5, 2024.
- ADHD Medication. Cleveland Clinic. October 6, 2022.
- NSAIDs: Do They Increase My Risk of Heart Attack and Stroke? Mayo Clinic. July 10, 2024.
- Lifestyle Steps When Managing Hypertrophic Cardiomyopathy. Mayo Clinic. April 7, 2025.
- Shortness of Breath. Hypertrophic Cardiomyopathy Association.